248 related articles for article (PubMed ID: 31127885)
1. The Therapeutic and Preventive Efficacy of Curcumin and Its Derivatives in Esophageal Cancer.
Komal K; Chaudhary S; Yadav P; Parmanik R; Singh M
Asian Pac J Cancer Prev; 2019 May; 20(5):1329-1337. PubMed ID: 31127885
[TBL] [Abstract][Full Text] [Related]
2. Chemopreventive and therapeutic potential of curcumin in esophageal cancer: Current and future status.
Hesari A; Azizian M; Sheikhi A; Nesaei A; Sanaei S; Mahinparvar N; Derakhshani M; Hedayt P; Ghasemi F; Mirzaei H
Int J Cancer; 2019 Mar; 144(6):1215-1226. PubMed ID: 30362511
[TBL] [Abstract][Full Text] [Related]
3. Effects of curcumin on stem-like cells in human esophageal squamous carcinoma cell lines.
Almanaa TN; Geusz ME; Jamasbi RJ
BMC Complement Altern Med; 2012 Oct; 12():195. PubMed ID: 23095512
[TBL] [Abstract][Full Text] [Related]
4. Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma.
Wilken R; Veena MS; Wang MB; Srivatsan ES
Mol Cancer; 2011 Feb; 10():12. PubMed ID: 21299897
[TBL] [Abstract][Full Text] [Related]
5. Novel T7-Modified pH-Responsive Targeted Nanosystem for Co-Delivery of Docetaxel and Curcumin in the Treatment of Esophageal Cancer.
Deng L; Zhu X; Yu Z; Li Y; Qin L; Liu Z; Feng L; Guo R; Zheng Y
Int J Nanomedicine; 2020; 15():7745-7762. PubMed ID: 33116498
[TBL] [Abstract][Full Text] [Related]
6. Prospective non-randomized study of preoperative concurrent platinum plus 5-fluorouracil-based chemoradiotherapy with or without paclitaxel in esophageal cancer patients: long-term follow-up.
Zemanova M; Petruzelka L; Pazdro A; Kralova D; Smejkal M; Pazdrova G; Honova H
Dis Esophagus; 2010 Feb; 23(2):160-7. PubMed ID: 19515190
[TBL] [Abstract][Full Text] [Related]
7. Potential application of curcumin and its analogues in the treatment strategy of patients with primary epithelial ovarian cancer.
Terlikowska KM; Witkowska AM; Zujko ME; Dobrzycka B; Terlikowski SJ
Int J Mol Sci; 2014 Nov; 15(12):21703-22. PubMed ID: 25429431
[TBL] [Abstract][Full Text] [Related]
8. Tetrahydrocurcumin, Curcumin, and 5-Fluorouracil Effects on Human Esophageal Carcinoma Cells.
Pendleton EG; Jamasbi RJ; Geusz ME
Anticancer Agents Med Chem; 2019; 19(8):1012-1020. PubMed ID: 30652650
[TBL] [Abstract][Full Text] [Related]
9. The Potential Clinical Value of Curcumin and its Derivatives in Colorectal Cancer.
Yao Z; Le TH; Du Q; Mu H; Liu C; Zhu Y
Anticancer Agents Med Chem; 2021; 21(13):1626-1637. PubMed ID: 33191888
[TBL] [Abstract][Full Text] [Related]
10. First-line chemotherapy improves the resection rate and long-term survival of locally advanced (T4, any N, M0) squamous cell carcinoma of the thoracic esophagus: final report on 163 consecutive patients with 5-year follow-up.
Ancona E; Ruol A; Castoro C; Chiarion-Sileni V; Merigliano S; Santi S; Bonavina L; Peracchia A
Ann Surg; 1997 Dec; 226(6):714-23; discussion 723-4. PubMed ID: 9409570
[TBL] [Abstract][Full Text] [Related]
11. [Neoadjuvant Therapy in Multimodal Surgical Treatment for Squamous Cell Carcinoma of the Esophagus].
Daiko H; Fujita T; Kojima T
Gan To Kagaku Ryoho; 2016 Oct; 43(10):1161-1165. PubMed ID: 27760933
[TBL] [Abstract][Full Text] [Related]
12. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
[TBL] [Abstract][Full Text] [Related]
13. Overall Survival of Patients with Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma Treated with Nimotuzumab in the Real World.
Saumell Y; Sanchez L; González S; Ortiz R; Medina E; Galán Y; Lage A
Adv Ther; 2017 Dec; 34(12):2638-2647. PubMed ID: 29134427
[TBL] [Abstract][Full Text] [Related]
14. Synthetic curcumin analog UBS109 inhibits the growth of head and neck squamous cell carcinoma xenografts.
Zhu S; Moore TW; Morii N; Howard RB; Culver D; Arrendale RF; Reddy P; Evers TJ; Zhang H; Sica G; Chen ZG; Sun A; Fu H; Khuri FR; Shin DM; Snyder JP; Shoji M
Curr Cancer Drug Targets; 2014; 14(4):380-93. PubMed ID: 24628271
[TBL] [Abstract][Full Text] [Related]
15. [Concomitant chemoradiotherapy of cancer of the esophagus].
Calais G
Cancer Radiother; 1998 Dec; 2(6):689-95. PubMed ID: 9922774
[TBL] [Abstract][Full Text] [Related]
16. Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies.
Allegra A; Innao V; Russo S; Gerace D; Alonci A; Musolino C
Cancer Invest; 2017 Jan; 35(1):1-22. PubMed ID: 27996308
[TBL] [Abstract][Full Text] [Related]
17. Nutraceuticals as new treatment approaches for oral cancer--I: Curcumin.
Zlotogorski A; Dayan A; Dayan D; Chaushu G; Salo T; Vered M
Oral Oncol; 2013 Mar; 49(3):187-91. PubMed ID: 23116961
[TBL] [Abstract][Full Text] [Related]
18. Preoperative chemotherapy for resectable thoracic esophageal cancer.
Malthaner R; Fenlon D
Cochrane Database Syst Rev; 2001; (1):CD001556. PubMed ID: 11279723
[TBL] [Abstract][Full Text] [Related]
19. Preclinical Study of Novel Curcumin Analogue SSC-5 Using Orthotopic Tumor Xenograft Model for Esophageal Squamous Cell Carcinoma.
Tung LN; Song S; Chan KT; Choi MY; Lam HY; Chan CM; Chen Z; Wang HK; Leung HT; Law S; Huang Y; Song H; Lee NP
Cancer Res Treat; 2018 Oct; 50(4):1362-1377. PubMed ID: 29361818
[TBL] [Abstract][Full Text] [Related]
20. Suppression of esophageal cancer cell growth using curcumin, (-)-epigallocatechin-3-gallate and lovastatin.
Ye F; Zhang GH; Guan BX; Xu XC
World J Gastroenterol; 2012 Jan; 18(2):126-35. PubMed ID: 22253518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
